| Title |
Value |
| Polysaccharide |
RMP1 |
| Source Name |
Morus alba L. |
| Weight |
|
| Main Glycosidic Bond(s) |
| β-Galp-(1→3) |
| β-Galp-(1→6) |
| β-Galp-(1→2) |
| α-Araf-(1→4) |
| β-Xylp-(1→3) |
|
| Main Chain |
The backbone of RMP1 consists of 1,3-β-D-Galp and 1,6-β-D-Galp residues. |
| Side Chain |
The side chains include 1,2-α-L-Araf, 1,4-β-D-Xylp, and 1,3,6-β-D-Galp. The terminals are α-L-Araf and β-D-Glcp. |
| NMR Information |
unknown
|
| Monosaccharide |
| glucose |
8.1% |
| galactose |
47.62% |
| xylose |
17.62% |
| arabinose |
26.67% |
|
| Physiological Functions |
RMP1 exhibited significant anticancer effects against SGC-7901 and HeLa cells in vitro, inducing apoptosis and cell cycle arres
|
| Intestinal Microbiota Regulation |
unknown
|
| Related Diseases (based on ICD-11) |
|
| Correlation map |
Click to view |
| DOI |
10.1016/j.carbpol.2018.02.036 |
Data Source Statement:
The data included in the DoLPHiN database is sourced exclusively from peer-reviewed original publications and presented after normalization.
